Related Experiment Video
Updated: Jun 22, 2026

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions
Published on: March 8, 2019
Circulating matrix metalloproteinase-9 concentrations and abdominal aortic aneurysm presence: a meta-analysis
Hisato Takagi1, Hideaki Manabe, Norikazu Kawai
1Department of Cardiovascular Surgery, Shizuoka Medical Center, Sunto-gun, Shizuoka 411-8611, Japan.
Abstract:
To summarize the present evidence for an association between matrix metalloproteinase-9 (MMP-9) and abdominal aortic aneurysm (AAA) presence, we performed a meta-analysis of case-control studies that compared circulating MMP-9 concentrations between patients with AAA and subjects without AAA. MEDLINE database was searched to identify all case-control studies. For each study, data regarding serum or plasma MMP-9 concentrations in both the AAA and control groups were used to generate standardized mean differences (SMDs) and 95% confidence intervals (CIs). Study-specific estimates were combined using inverse variance-weighted average of logarithmic SMDs in both fixed- and random-effects models. Our search identified eight eligible studies including 580 patients with AAA and 258 subjects without AAA. Pooled analysis demonstrated significantly higher circulating MMP-9 concentrations in the AAA group than those in the control group in random-effect models (SMD, 0.70; 95% CI, 0.23-1.17; P=0.004). There was significant study heterogeneity of results (P<0.00001) but no evidence of significant publication bias (P=0.1376). We found that, based on a systematic review and meta-analysis, circulating MMP-9 concentrations are higher in patients with AAA than those in subjects without AAA. Higher circulating MMP-9 concentrations are associated with AAA presence.
Insights
Elevated levels of matrix metalloproteinase-9 (MMP-9) are significantly associated with the presence of abdominal aortic aneurysm (AAA). This meta-analysis confirms higher MMP-9 concentrations in AAA patients compared to controls.
Area of Science:
- Cardiovascular Research
- Biomarker Discovery
- Medical Diagnostics
Background:
- Abdominal aortic aneurysm (AAA) is a life-threatening condition.
- Matrix metalloproteinase-9 (MMP-9) is implicated in vascular remodeling and aneurysm formation.
- Understanding biomarkers for AAA is crucial for early detection and management.
Purpose of the Study:
- To systematically review and meta-analyze evidence on the association between circulating MMP-9 levels and AAA presence.
- To quantify the difference in MMP-9 concentrations between AAA patients and control subjects.
Main Methods:
- A meta-analysis of case-control studies was conducted.
- Studies were identified through a MEDLINE database search.
- Circulating MMP-9 concentrations were compared between AAA and control groups using standardized mean differences (SMDs).
Main Results:
- Eight studies with 580 AAA patients and 258 controls were included.
- Pooled analysis revealed significantly higher circulating MMP-9 concentrations in the AAA group (SMD, 0.70; 95% CI, 0.23-1.17; P=0.004).
- Significant heterogeneity was observed across studies, but no publication bias was detected.
Conclusions:
- Circulating MMP-9 concentrations are elevated in individuals with abdominal aortic aneurysm.
- Higher MMP-9 levels are associated with the presence of AAA, suggesting its potential as a biomarker.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm III: Interprofessional Care
Role of Matrix Metalloproteases in Degradation of ECM
A...
Aneurysm I: Introduction

